{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:47:55Z","timestamp":1792010875835,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["My First AIRC Grant 2022 #ID27254"],"award-info":[{"award-number":["My First AIRC Grant 2022 #ID27254"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["Grant #IG30434"],"award-info":[{"award-number":["Grant #IG30434"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN MIUR 2020 #2020Z73J5A"],"award-info":[{"award-number":["PRIN MIUR 2020 #2020Z73J5A"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08287-8","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T15:43:01Z","timestamp":1780155781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A brain-penetrant chimeric protein combines direct glioma targeting with myeloid cell-mediated immune reprogramming"],"prefix":"10.1186","volume":"24","author":[{"given":"Elisabetta","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Scalera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Meissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ellmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Flori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Menichetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudula","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Angiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1337-3901","authenticated-orcid":false,"given":"Eleonora","family":"Vannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"8287_CR1","doi-asserted-by":"publisher","unstructured":"De Simone M, Conti V, Palermo G, De Maria L, Iaconetta G. Advancements glioma care: focus emerg neurosurgical techniques. Biomedicines. 2024;12. https:\/\/doi.org\/10.3390\/biomedicines12010008.","DOI":"10.3390\/biomedicines12010008"},{"key":"8287_CR2","doi-asserted-by":"publisher","first-page":"IV1","DOI":"10.1093\/neuonc\/noad149","volume":"25","author":"QT Ostrom","year":"2023","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016\u20132020. Neuro Oncol. 2023;25:IV1\u201399.","journal-title":"Neuro Oncol"},{"key":"8287_CR3","doi-asserted-by":"publisher","unstructured":"Obrador E, Moreno-Murciano P, Oriol-Caballo M, L\u00f3ppez-Blanch R, Pineda B, Guti\u00e9rrez-Arroyo JL, Loras A, Gonzalez-Bonet LG, Martinez-Cadenas C, Estrela JM, Marqu\u00e9s-Torrej\u00f3n M\u00c1. Glioblastoma Therapy: Past, Present and Future. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/ijms25052529.","DOI":"10.3390\/ijms25052529"},{"key":"8287_CR4","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.3390\/ijms25115774","volume":"25","author":"K Sadowski","year":"2024","unstructured":"Sadowski K, Ja\u017cd\u017cewska A, Koz\u0142owski J, Zacny A, Lorenc T, Olejarz W. Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches. Int J Mol Sci. 2024;25:5774.","journal-title":"Int J Mol Sci"},{"key":"8287_CR5","doi-asserted-by":"crossref","unstructured":"Yang C, Cheng E, Wang A, editors. Unravelling glioblastoma heterogeneity by single-cell RNA sequencing. 2024;12924:163\u2013174. https:\/\/doi.org\/10.1117\/12.3013140.","DOI":"10.1117\/12.3013140"},{"key":"8287_CR6","doi-asserted-by":"publisher","first-page":"216610","DOI":"10.1016\/j.canlet.2024.216610","volume":"584","author":"S Yang","year":"2024","unstructured":"Yang S, Wang M, Hua Y, Li J, Zheng H, Cui M, Huang N, Liu Q, Liao Q. Advanced insights on tumor-associated macrophages revealed by single-cell RNA sequencing: The intratumor heterogeneity, functional phenotypes, and cellular interactions. Cancer Lett. 2024;584:216610.","journal-title":"Cancer Lett"},{"key":"8287_CR7","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/s41590-019-0433-y","volume":"20","author":"CM Jackson","year":"2019","unstructured":"Jackson CM, Choi J, Lim M. Mechanisms of immunotherapy resistance: lessons from glioblastoma. Nat Immunol. 2019;20:1100\u20139.","journal-title":"Nat Immunol"},{"key":"8287_CR8","doi-asserted-by":"publisher","first-page":"1299064","DOI":"10.3389\/fimmu.2023.1299064","volume":"14","author":"TA Mishchenko","year":"2024","unstructured":"Mishchenko TA, Turubanova VD, Gorshkova EN, Krysko O, Vedunova MV. Krysko, Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy. Front Immunol. 2024;14:1299064.","journal-title":"Front Immunol"},{"key":"8287_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","volume":"8","author":"S Wang","year":"2024","unstructured":"Wang S, Wang J, Chen Z, Luo J, Guo W, Sun L, Lin L. Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. NPJ Precis Oncol. 2024;8:31.","journal-title":"NPJ Precis Oncol"},{"key":"8287_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3389\/fonc.2018.00462","volume":"8","author":"BG Harder","year":"2018","unstructured":"Harder BG, Blomquist MR, Wang J, Kim AJ, Woodworth GF, Winkles JA, Loftus JC. Tran, Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma. Front Oncol. 2018;8:462.","journal-title":"Front Oncol"},{"key":"8287_CR11","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/neuonc\/now114","volume":"18","author":"E Vannini","year":"2016","unstructured":"Vannini E, Olimpico F, Middei S, Ammassari-Teule M, De Graaf EL, McDonnell L, Schmidt G, Fabbri A, Fiorentini C, Baroncelli L, Costa M, Caleo M. Electrophysiology of glioma: a Rho GTPase-activating protein reduces tumor growth and spares neuron structure and function. Neuro Oncol. 2016;18:1634\u201343.","journal-title":"Neuro Oncol"},{"key":"8287_CR12","doi-asserted-by":"publisher","first-page":"23539","DOI":"10.18632\/oncotarget.15328","volume":"8","author":"E Vannini","year":"2017","unstructured":"Vannini E, Maltese F, Olimpico F, Fabbri A, Costa M, Caleo M, Baroncelli L. Progression of motor deficits in glioma-bearing mice: Impact of CNF1 therapy at symptomatic stages. Oncotarget. 2017;8:23539\u201350.","journal-title":"Oncotarget"},{"key":"8287_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/NOAJNL\/VDAF003","author":"N Cayuela","year":"2025","unstructured":"Cayuela N, Izquierdo C, Vaquero L, C\u00e0mara E, Bruna J, Sim\u00f3 M. Mapping Glioma\u2019s Impact on Cognition: Insights from Macrostructure, Microstructure and Beyond. Neurooncol Adv. 2025. https:\/\/doi.org\/10.1093\/NOAJNL\/VDAF003.","journal-title":"Neurooncol Adv"},{"key":"8287_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/CCO.0000000000000581","volume":"31","author":"MB Coomans","year":"2019","unstructured":"Coomans MB, van der Linden SD, Gehring K, Taphoorn MJB. Treatment of cognitive deficits in brain tumour patients: current status and future directions. Curr Opin Oncol. 2019;31:540.","journal-title":"Curr Opin Oncol"},{"key":"8287_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-14-449","volume":"14","author":"E Vannini","year":"2014","unstructured":"Vannini E, Panighini A, Cerri C, Fabbri A, Lisi S, Pracucci E, Benedetto N, Vannozzi R, Fiorentini C, Caleo M, Costa M. The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model. BMC Cancer. 2014;14:1\u201310.","journal-title":"BMC Cancer"},{"key":"8287_CR16","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1128\/IAI.71.3.1161-1169.2003","volume":"71","author":"P Brest","year":"2003","unstructured":"Brest P, Mograbi B, Hofman V, Loubat A, Rossi B, Auberger P, Hofman P. Rho GTPase is activated by cytotoxic necrotizing factor 1 in peripheral blood T lymphocytes: Potential cytotoxicity for intestinal epithelial cells. Infect Immun. 2003;71:1161\u20139.","journal-title":"Infect Immun"},{"key":"8287_CR17","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.3390\/ijms19051408","volume":"19","author":"L Gall-Mas","year":"2018","unstructured":"Gall-Mas L, Fabbri A, Namini M, Givskov M, Fiorentini C, Krejsgaard T. The Bacterial Toxin CNF1 Induces Activation and Maturation of Human Monocyte-Derived Dendritic Cells. Int J Mol Sci. 2018;19:1408.","journal-title":"Int J Mol Sci"},{"key":"8287_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/toxins12050291","volume":"12","author":"A Colarusso","year":"2020","unstructured":"Colarusso A, Maroccia Z, Parrilli E, Germinario EAP, Fortuna A, Loizzo S, Ricceri L, Tutino ML, Fiorentini C, Fabbri A. Cnf1 Variants Endowed with the Ability to Cross the Blood-Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma. Toxins (Basel). 2020;12:1\u201314.","journal-title":"Toxins (Basel)"},{"key":"8287_CR19","doi-asserted-by":"publisher","unstructured":"Vannini E, Mori E, Tantillo E, Schmidt G, Caleo M, Costa M. CTX-CNF1 recombinant protein selectively targets glioma cells in vivo. Toxins (Basel). 2021;13. https:\/\/doi.org\/10.3390\/toxins13030194.","DOI":"10.3390\/toxins13030194"},{"key":"8287_CR20","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.3390\/cancers15133388","volume":"15","author":"T Boltman","year":"2023","unstructured":"Boltman T, Meyer M, Ekpo O. Diagnostic and therapeutic approaches for glioblastoma and neuroblastoma cancers using chlorotoxin nanoparticles. Cancers (Basel). 2023;15:3388.","journal-title":"Cancers (Basel)"},{"key":"8287_CR21","doi-asserted-by":"publisher","unstructured":"Majc B, Novak M, Lah TT, Kri\u017eaj I. Bioactive peptides from venoms against glioma progression. Front Oncol. 2022;12. https:\/\/doi.org\/10.3389\/fonc.2022.965882.","DOI":"10.3389\/fonc.2022.965882"},{"key":"8287_CR22","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jconrel.2022.08.051","volume":"350","author":"B Sethi","year":"2022","unstructured":"Sethi B, Kumar V, Mahato K, Coulter DW, Mahato RI. Recent advances in drug delivery and targeting to the brain. J Controlled Release. 2022;350:668\u201387.","journal-title":"J Controlled Release"},{"key":"8287_CR23","doi-asserted-by":"publisher","first-page":"100830","DOI":"10.1016\/j.conctc.2021.100830","volume":"23","author":"M Yamada","year":"2021","unstructured":"Yamada M, Miller DM, Lowe M, Rowe C, Wood D, Soyer HP, Byrnes-Blake K, Parrish-Novak J, Ishak L, Olson JM, Brandt G, Griffin P, Spelman L, Prow TW. A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients. Contemp Clin Trials Commun. 2021;23:100830.","journal-title":"Contemp Clin Trials Commun"},{"key":"8287_CR24","doi-asserted-by":"publisher","unstructured":"Wang D, Starr R, Chang WC, Aguilar B, Alizadeh D, Wright SL, Yang X, Brito A, Sarkissian A, Ostberg JR, Li L, Shi Y, Gutova M, Aboody K, Badie B, Forman SJ, Barish ME, Brown CE. Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma. Sci Transl Med. 2020;12. https:\/\/doi.org\/10.1126\/scitranslmed.aaw2672.","DOI":"10.1126\/scitranslmed.aaw2672"},{"key":"8287_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4161\/cc.5.1.2271","volume":"5","author":"EW Newcomb","year":"2006","unstructured":"Newcomb EW, Lymberis SC, Lukyanov Y, Shao Y, Schnee T, Devitt M, Rosenstein BS, Zagzag D, Formenti SC. Radiation Sensitivity of GL261 Murine Glioma Model and Enhanced Radiation Response by Flavopiridol. Cell Cycle. 2006;5:93\u20139.","journal-title":"Cell Cycle"},{"key":"8287_CR26","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.cmet.2020.07.016","volume":"32","author":"A Alexander Hooftman","year":"2020","unstructured":"Alexander Hooftman A, Angiari S, Hester S, Irvine AD, Fischer R, O LA, Hooftman A, Corcoran SE, Runtsch MC, Ling C, Ruzek MC, Slivka PF, McGettrick AF, Banahan K. Hughes, The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation In Brief ll The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation. Cell Metab. 2020;32:468\u2013e4787.","journal-title":"Cell Metab"},{"key":"8287_CR27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cmet.2019.10.015","volume":"31","author":"S Angiari","year":"2020","unstructured":"Angiari S, Runtsch MC, Sutton CE, Palsson-McDermott EM, Kelly B, Rana N, Kane H, Papadopoulou G, Pearce EL, Mills KHG, O\u2019Neill LAJ. Pharmacological Activation of Pyruvate Kinase M2 Inhibits CD4\u2009+\u2009T Cell Pathogenicity and Suppresses Autoimmunity. Cell Metab. 2020;31:391\u2013e4058.","journal-title":"Cell Metab"},{"key":"8287_CR28","doi-asserted-by":"publisher","unstructured":"Riva M, Wouters R, Weerasekera A, Belderbos S, Nittner D, Thal DR, Baert T, Giovannoni R, Gsell W, Himmelreich U, Van Ranst M, Coosemans A. CT-2A neurospheres-derived high-grade glioma in mice: a new model to address tumor stem cells and immunosuppression. Biol Open. 2019;8. https:\/\/doi.org\/10.1242\/BIO.044552.","DOI":"10.1242\/BIO.044552"},{"key":"8287_CR29","doi-asserted-by":"publisher","unstructured":"Spalletti C, Alia C, Lai S, Panarese A, Conti S, Micera S, Caleo M. Combining robotic training and inactivation of the healthy hemisphere restores pre-stroke motor patterns in mice. Elife. 2017;6. https:\/\/doi.org\/10.7554\/ELIFE.28662.","DOI":"10.7554\/ELIFE.28662"},{"key":"8287_CR30","doi-asserted-by":"publisher","first-page":"105780","DOI":"10.1016\/j.phrs.2021.105780","volume":"171","author":"W Wu","year":"2021","unstructured":"Wu W, Klockow JL, Zhang M, Lafortune F, Chang E, Jin L, Wu Y, Daldrup-Link HE. Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. Pharmacol Res. 2021;171:105780.","journal-title":"Pharmacol Res"},{"key":"8287_CR31","doi-asserted-by":"publisher","first-page":"16900","DOI":"10.1038\/s41598-020-73746-1","volume":"10","author":"X Wang","year":"2020","unstructured":"Wang X, Zhou C, Wang L, Wang Y, Jiang T. Motor cortex gliomas induces microstructural changes of large fiber tracts revealed by TBSS. Sci Rep. 2020;10:16900.","journal-title":"Sci Rep"},{"key":"8287_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28523-1","author":"VM Ravi","year":"2022","unstructured":"Ravi VM, Neidert N, Will P, Joseph K, Maier JP, K\u00fcckelhaus J, Vollmer L, Goeldner JM, Behringer SP, Scherer F, Boerries M, Follo M, Weiss T, Delev D, Kernbach J, Franco P, Schallner N, Dierks C, Carro MS, Hofmann UG, Fung C, Sankowski R, Prinz M, Beck J, Sali\u00e9 H, Bengsch B, Schnell O, Heiland DH. T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10. Nat Commun. 2022. https:\/\/doi.org\/10.1038\/s41467-022-28523-1.","journal-title":"Nat Commun"},{"key":"8287_CR33","doi-asserted-by":"crossref","unstructured":"Akkari L, Bowman RL, Tessier J, Klemm F, Handgraaf SM, de Groot M, Quail DF, Tillard L, Gadiot J, Huse JT, Brandsma D, Westerga J, Watts C, Joyce JA. Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance. 2020. http:\/\/stm.sciencemag.org\/.","DOI":"10.1126\/scitranslmed.aaw7843"},{"key":"8287_CR34","doi-asserted-by":"crossref","unstructured":"Yang T, Kong Z, Ma W. PD-1\/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential. Hum Vaccin Immunother. 2021:1\u20138.","DOI":"10.1080\/21645515.2020.1782692"},{"key":"8287_CR35","doi-asserted-by":"publisher","unstructured":"Khalsa JK, Cheng N, Keegan J, Chaudry A, Driver J, Bi WL, Lederer J, Shah K. Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types. Nat Commun. 2020;11. https:\/\/doi.org\/10.1038\/s41467-020-17704-5.","DOI":"10.1038\/s41467-020-17704-5"},{"key":"8287_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11060-023-04536-8","volume":"166","author":"N Yadav","year":"2024","unstructured":"Yadav N, Purow BW. Understanding current experimental models of glioblastoma-brain microenvironment interactions. J Neurooncol. 2024;166:213\u201329.","journal-title":"J Neurooncol"},{"key":"8287_CR37","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/neuonc\/noaa050","volume":"22","author":"CJ Liu","year":"2020","unstructured":"Liu CJ, Schaettler M, Blaha DT, Bowman-Kirigin JA, Kobayashi DK, Livingstone AJ, Bender D, Miller CA, Kranz DM, Johanns TM, Dunn GP. Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine. Neuro Oncol. 2020;22:1276\u201388.","journal-title":"Neuro Oncol"},{"key":"8287_CR38","doi-asserted-by":"crossref","unstructured":"Miyazaki T, Ishikawa E, Sugii N, Matsuda M. Therapeutic strategies for overcoming immunotherapy resistance mediated by immunosuppressive factors of the glioblastoma microenvironment. Cancers (Basel). 2020;12:1\u201321.","DOI":"10.3390\/cancers12071960"},{"key":"8287_CR39","unstructured":"Gibson EM, Monje M. Microglia in cancer therapy\u2013related cognitive impairment. Trends Neurosci. 2021:1\u201311."},{"key":"8287_CR40","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1128\/IAI.71.7.4178-4181.2003","volume":"71","author":"L Falzano","year":"2003","unstructured":"Falzano L, Quaranta MG, Travaglione S, Filippini P, Fabbri A, Viora M, Donelli G, Fiorentini C. Cytotoxic Necrotizing Factor 1 Enhances Reactive Oxygen Species-Dependent Transcription and Secretion of Proinflammatory Cytokines in Human Uroepithelial Cells. Infect Immun. 2003;71:4178\u201381.","journal-title":"Infect Immun"},{"key":"8287_CR41","doi-asserted-by":"publisher","unstructured":"Michel G, Ferrua B, Munro P, Boyer L, Mathal N, Gillet D, Marty P, Lemichez E. Immunoadjuvant properties of the rho activating factor CNF1 in prophylactic and curative vaccination against Leishmania infantum. PLoS ONE. 2016;11. https:\/\/doi.org\/10.1371\/journal.pone.0156363.","DOI":"10.1371\/journal.pone.0156363"},{"key":"8287_CR42","doi-asserted-by":"publisher","first-page":"8702","DOI":"10.1016\/j.vaccine.2007.10.024","volume":"25","author":"P Munro","year":"2007","unstructured":"Munro P, Flatau G, Lemichez E. Intranasal immunization with tetanus toxoid and CNF1 as a new mucosal adjuvant protects BALB\/c mice against lethal challenge. Vaccine. 2007;25:8702\u20136.","journal-title":"Vaccine"},{"key":"8287_CR43","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/j.vaccine.2004.11.042","volume":"23","author":"P Munro","year":"2005","unstructured":"Munro P, Flatau G, Anju\u00e8re F, Hofman V, Czerkinsky C, Lemichez E. The Rho GTPase activators CNF1 and DNT bacterial toxins have mucosal adjuvant properties. Vaccine. 2005;23:2551\u20136.","journal-title":"Vaccine"},{"key":"8287_CR44","doi-asserted-by":"publisher","unstructured":"Li G, Yang H, Ke T, Tan N, Du X, Duan X, Zhou X, Zheng G, Liao C. Escherichia coli combination with PD-1 blockade synergistically enhances immunotherapy in glioblastoma multiforme by regulating the immune cells. J Transl Med. 2025;23. https:\/\/doi.org\/10.1186\/s12967-025-06194-y.","DOI":"10.1186\/s12967-025-06194-y"},{"key":"8287_CR45","doi-asserted-by":"publisher","first-page":"166","DOI":"10.7150\/jca.4149","volume":"3","author":"E Binello","year":"2012","unstructured":"Binello E, Qadeer ZA, Kothari HP, Emdad L, Germano IM. Stemness of the CT-2A immunocompetent mouse brain tumor model: characterization in vitro. J Cancer. 2012;3:166.","journal-title":"J Cancer"},{"key":"8287_CR46","doi-asserted-by":"publisher","unstructured":"Ghouzlani A, Kandoussi S, Tall M, Reddy KP, Rafii S, Badou A. Immune Checkp Inhibitors Hum Glioma MicroenvironmentFront Immunol. 2021;12. https:\/\/doi.org\/10.3389\/fimmu.2021.679425.","DOI":"10.3389\/fimmu.2021.679425"},{"key":"8287_CR47","doi-asserted-by":"crossref","unstructured":"Look T, Sankowski R, Bouzereau M, Fazio S, Sun M, Buck A, Binder N, Mastall M, Prisco F, Seehusen F, Frei J, Wyss C, Snijder B, Nombela Arrieta C, Weller M, Pascolo S, Weiss T. CAR T cells, CAR NK cells, and CAR macrophages exhibit distinct traits in glioma models but are similarly enhanced when combined with cytokines. Cell Rep Med. 2025:101931.","DOI":"10.1016\/j.xcrm.2025.101931"}],"updated-by":[{"DOI":"10.1186\/s12967-026-09089-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000}}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08287-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08287-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08287-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:11:31Z","timestamp":1792008691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08287-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8287"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08287-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Article updated to correct the author\u2019s name format.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Article updated to correct the typo errors in text.","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":10,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":11,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12967-026-09089-8","URL":"https:\/\/doi.org\/10.1186\/s12967-026-09089-8","order":13,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures conformed to the European Communities Council Directive #86\/609\/EEC were approved by the Italian Ministry of Health (1204\/2020-PR, prot. B4BB8.30 del 02\/10\/2020). Human buffy coats were obtained from the Transfusion Medicine Department of the Medical University of Graz, where blood donors had signed informed consent prior to collection, in accordance with the Declaration of Helsinki. These buffy coats were purchased by the Division of Immunology and processed anonymously.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have given their consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors E. Vannini, M. Costa, E. Mori, A. Cattaneo, G. Schmidt, and S. Angiari are inventors on a patent application related to this work: PCT application WO2026069258A1, entitled \u201cEffect of CTX-CNF1 on the Switch of Macrophages Towards a Pro-Inflammatory Phenotype\u201d, Italian patent application No. IT102024000021636, filed on September 30, 2024.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"986"}}